Back to search

Netherlands· NL-738dc89282fa

Akeega 50 mg/500 mg filmomhulde tabletten

A antineoplastic agents product containing abirateronacetaat + niraparibtosilaat 1-water, registered in Netherlands by Janssen-Cilag International NV. The same ATC class is registered in 6 of our 19 countries.

ATC L01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAkeega 50 mg/500 mg filmomhulde table…ATCL01REGISTER NO.NL-738dc89282faPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Abirateronacetaat + niraparibtosilaat 1-water is registered in 6 of 19 countries.

Countries holding a registration under ATC L01 (antineoplastic agents), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose

Abirateronacetaat + niraparibtosilaat 1-water · ATC L01

6 / 19 countries

  • Canada
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ABIRATERONACETAAT + NIRAPARIBTOSILAAT 1-WATER
Manufacturer
Janssen-Cilag International NV
Country
Netherlands (NL)
ATC code
L01
ATC class
ANTINEOPLASTIC AGENTS
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/23/1722

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Abirateronacetaat + niraparibtosilaat 1-water in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All abirateronacetaat + niraparibtosilaat 1-water products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Akeega
  • Liechtenstein · Akeega
  • Norway · Akeega

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/84c0e8bc-7502-4804-97ce-56904f8f6d09
GET /v1/drugs/84c0e8bc-7502-4804-97ce-56904f8f6d09?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/akeega-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Antineoplastic Agents",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130001",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "GLYCEROL MONOCAPRYLOCAPRAAT, TYPE I",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "POLYVINYLALCOHOL (E 1203)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ABIRATERONACETAAT",
    "NIRAPARIBTOSILAAT 1-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "2023/04/19",
  "procedure_number": "EMEA/H/C/005932",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/23/1722",
  "additional_monitoring": "N"
}

See everything about abirateronacetaat + niraparibtosilaat 1-water.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.